Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
An approachable overview comparing passive retirement investing using index funds versus ETFs, highlighting costs, flexibility, and long-term potential.
25,613 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Fundstrat co-founder Tom Lee points to the ETH/BTC ratio as a sign of a potential leadership shift in crypto, suggest...
U.S. stocks climbed on Tuesday as inflation cooled more than expected, helping the S&P 500 regain ground. Futures poi...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
The World Cup has unleashed a vigorous rise in prediction markets, with activity hitting a sizable share of US sports...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
New data shows ULTY's steep cost, via a 1.24% expense ratio, quietly chewing into returns even as distributions persi...
Freddie Mac data show mortgage rates jump highest in nearly a year, with the 30-year fixed at about 6.55% as buyers w...
Federal health officials tie lettuce from mexico sold to Taco Bell and other outlets to a cyclospora outbreak spannin...
A leading MIT AI researcher warns that rushing automation in Gen Z entry-level roles could undermine on-the-job learn...
Afriski, Lesotho's country’s only fully operational ski resort, keeps winter tourism alive and feeds local incomes as...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...